 |
|
|
 |
|
Rationale:
- Patients with moderate to severe hypothermia should be handled gently because sudden movements or manipulations (endotracheal
intubation, suctioning, lifting) can trigger malignant arrhythmias.
- Removal of wet clothing decreases conduction heat away from the patient.
- Transportation to a medical center provides access to advanced medical care and equipment.
- Warm intravenous fluids (normal saline with 5% dextrose or one-half normal saline with dextrose for hypernatremia) are used
for the treatment of hypovolemia and decreased blood viscosity.
- The general approach to treat hypothermia is to use an active rewarming strategy, which may include forced-air warming blankets,
circulating-water mattresses, electric blankets, radiant warmers, warm intravenous fluids, peritoneal lavage, extracorporeal
rewarming (veno-venous or arterial-venous bypass), gastric lavage, or thoracic lavage.
|
|
Evidence:
- Rough movements or transportation of the hypothermia victim can provoke severe arrhythmias and ventricular fibrillation. Knowledge
of the pathophysiology of hypothermia allows for early diagnosis and initiation of therapy to limit morbidity (37; 112).
- Studies of hypothermic trauma victims and volunteer subjects show the superiority of active rewarming versus passive rewarming
(i.e., insulation), significantly reducing the volume of fluid needed for resuscitation as well as short-term mortality (145; 146; 147).
|
|
Comments:
- In trauma patients, hypothermia correlates with the severity of injury but is independently associated with worse outcomes.
In one series, mortality in patients with core temperatures <34°C (93.2°F) was 40% compared to 7% for those with core temperatures
34°C (93.2°F) (148).
|
| FAQs |
|
|
|
Albert Cheung, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Dmitri Guvakov, MD, PhD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Stuart Weiss, MD, PhD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Wenjun Zhou Martini, PhD, editorial consultant, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Darren B. Taichman, MD, PhD, Editor, PIER, has received grant support from Actelion Pharmaceuticals Ltd , and honoraria for
continuing medical education grand rounds and lectures given.
|
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted (c) 2010 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
|